Advisor Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $442K | Sell |
45,080
-8,559
| -16% | -$83.9K | ﹤0.01% | 1761 |
|
|
2019
Q3 | $368K | Buy |
53,639
+2,264
| +4% | +$15.5K | ﹤0.01% | 1837 |
|
|
2019
Q2 | $473K | Buy |
51,375
+2,101
| +4% | +$19.3K | ﹤0.01% | 1656 |
|
|
2019
Q1 | $773K | Sell |
49,274
-5,948
| -11% | -$93.3K | 0.01% | 1275 |
|
|
2018
Q4 | $851K | Buy |
55,222
+5,281
| +11% | +$81.4K | 0.01% | 1039 |
|
|
2018
Q3 | $1.08M | Buy |
49,941
+24,473
| +96% | +$527K | 0.01% | 940 |
|
|
2018
Q2 | $620K | Sell |
25,468
-1,881
| -7% | -$45.8K | 0.01% | 1163 |
|
|
2018
Q1 | $467K | Buy |
27,349
+1,748
| +7% | +$29.8K | 0.01% | 1373 |
|
|
2017
Q4 | $484K | Sell |
25,601
-7,120
| -22% | -$135K | 0.01% | 1348 |
|
|
2017
Q3 | $576K | Buy |
32,721
+8,171
| +33% | +$144K | 0.01% | 1110 |
|
|
2017
Q2 | $816K | Buy |
24,550
+6,067
| +33% | +$202K | 0.01% | 857 |
|
|
2017
Q1 | $593K | Buy |
18,483
+5,106
| +38% | +$164K | 0.01% | 973 |
|
|
2016
Q4 | $485K | Sell |
13,377
-3,331
| -20% | -$121K | 0.01% | 1036 |
|
|
2016
Q3 | $769K | Buy |
16,708
+665
| +4% | +$30.6K | 0.02% | 748 |
|
|
2016
Q2 | $803K | Buy |
+16,043
| New | +$803K | 0.02% | 698 |
|